This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ocera Therapeutics, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Linda S. Grais: Innovator in Liver Disease Treatment
Introduction
Linda S. Grais is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of medicine, particularly in the treatment of liver diseases. Her innovative work focuses on alternative administration routes for essential medications.
Latest Patents
Linda holds a patent for "Formulations of L-ornithine phenylacetate." This patent describes oral formulations of L-ornithine phenylacetate and methods for their use. These formulations provide an alternative to the standard intravenous administration for treating hyperammonemia in patients with various acute and chronic liver diseases. Conditions such as acute liver failure, liver cirrhosis, and hepatic encephalopathy can benefit from her innovative approach.
Career Highlights
Linda is associated with Ocera Therapeutics, Inc., where she continues to develop her groundbreaking work. Her dedication to improving patient outcomes in liver disease treatment is evident in her research and patent contributions.
Collaborations
Linda collaborates with talented professionals in her field, including Laurene Wang and Stanley Bukofzer. Their combined expertise enhances the development of innovative solutions for liver disease management.
Conclusion
Linda S. Grais is a trailblazer in the medical field, particularly in the treatment of liver diseases. Her patent for L-ornithine phenylacetate formulations showcases her commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile